UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MET in human cancer: germline and somatic mutations

Annals of translational medicine, 2017-05, Vol.5 (10), p.205-205

2017

Volltextzugriff (PDF)

Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

Cancer & metabolism, 2017-08, Vol.5 (1), p.6-6, Article 6

2017

Volltextzugriff (PDF)

Stromal Expression of miR-21 Identifies High-Risk Group in Triple-Negative Breast Cancer

The American journal of pathology, 2014-12, Vol.184 (12), p.3217-3225

2014

Volltextzugriff (PDF)

NF1 deficiency drives metabolic reprogramming in ER+ breast cancer

Molecular metabolism (Germany), 2024-02, Vol.80, p.101876-101876, Article 101876

2024

Volltextzugriff (PDF)

Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2009-08, Vol.106 (31), p.12909-12914

2009

Volltextzugriff (PDF)

Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling

Epigenetics & chromatin, 2021-01, Vol.14 (1), p.7-7, Article 7

2021

Volltextzugriff (PDF)

Wnt/β-catenin Signaling in Normal and Cancer Stem Cells

Cancers, 2011-04, Vol.3 (2), p.2050-2079

2011

Volltextzugriff (PDF)

Nf1 deficiency modulates the stromal environment in the pretumorigenic rat mammary gland

Frontiers in cell and developmental biology, 2024, Vol.12, p.1375441-1375441

2024

Volltextzugriff (PDF)

Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities

Genes, 2020-03, Vol.11 (3), p.331

2020

Volltextzugriff (PDF)

ceas: an R package for Seahorse data analysis and visualization

Bioinformatics (Oxford, England), 2024-08, Vol.40 (8)

2024

Volltextzugriff (PDF)

MET: a critical player in tumorigenesis and therapeutic target

Cold Spring Harbor perspectives in biology, 2013-07, Vol.5 (7), p.a009209-a009209

2013

Volltextzugriff (PDF)

The Identification of E2F1-Specific Target Genes

Proceedings of the National Academy of Sciences - PNAS, 2002-03, Vol.99 (6), p.3890-3895

2002

Volltextzugriff (PDF)

Ex Vivo Patient-Derived Explant Model for Neurofibromatosis Type 1–Related Cutaneous Neurofibromas

Journal of investigative dermatology, 2024-09, Vol.144 (9), p.2052-2065.e8

2024

Volltextzugriff (PDF)

Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13), p.3672-3687

2018

Volltextzugriff (PDF)

Germline met mutations in mice reveal mutation- and background-associated differences in tumor profiles

PloS one, 2010-10, Vol.5 (10), p.e13586-e13586

2010

Volltextzugriff (PDF)

p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs

Oncogene, 2024-05, Vol.43 (19), p.1411-1430

2024

Volltextzugriff (PDF)

Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models

Clinical cancer research, 2016-02, Vol.22 (4), p.923-934

2016

Volltextzugriff (PDF)

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

Oncotarget, 2016-10, Vol.7 (43), p.69903-69915

2016

Volltextzugriff (PDF)

Critical analysis of the potential for microRNA biomarkers in breast cancer management

Breast cancer targets and therapy, 2015-01, Vol.7 (default), p.59-79

2015

Volltextzugriff (PDF)

UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Clinical cancer research, 2016-10, Vol.22 (20), p.5087-5096

2016

Volltextzugriff (PDF)

Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Clinical cancer research, 2020-04, Vol.26 (7), p.1777-1777

2020

Volltextzugriff (PDF)

Expression profiling and identification of novel genes in hepatocellular carcinomas

Oncogene, 2001-05, Vol.20 (21), p.2704-2712

2001

Volltextzugriff (PDF)

A Mouse Model of Activating Met Mutations

Cell cycle (Georgetown, Tex.), 2005-04, Vol.4 (4), p.518-520

2005

Volltextzugriff (PDF)

MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance

Molecular cancer research, 2013-09, Vol.11 (9), p.1112-1121

2013

Volltextzugriff (PDF)

NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer

NPJ breast cancer, 2018-08, Vol.4 (1), p.29-14, Article 29

2018

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(38)
Reviews
(1)

Sprache

Englisch
(39)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(24)
Animals
(14)
Oncology
(14)
Humans
(13)
Mice
(13)
Cell Biology
(10)
Tumors
(9)
Female
(7)
Breast Cancer
(6)
Gene Expression
(6)
Mutation
(6)
Proto-Oncogene Proteins C-Met - Genetics
(6)
Signal Transduction
(6)
Biochemistry & Molecular Biology
(5)
Cancer
(5)
Cell Line, Tumor
(5)
Gene Expression Regulation, Neoplastic
(5)
Genetics & Heredity
(5)
Genetic Disorders
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

MET in human cancer: germline and somatic mutations

Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

Stromal Expression of miR-21 Identifies High-Risk Group in Triple-Negative Breast Cancer

NF1 deficiency drives metabolic reprogramming in ER+ breast cancer

Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer

Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling

Wnt/β-catenin Signaling in Normal and Cancer Stem Cells

Nf1 deficiency modulates the stromal environment in the pretumorigenic rat mammary gland

Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities

ceas: an R package for Seahorse data analysis and visualization

MET: a critical player in tumorigenesis and therapeutic target

The Identification of E2F1-Specific Target Genes

Ex Vivo Patient-Derived Explant Model for Neurofibromatosis Type 1–Related Cutaneous Neurofibromas

Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors

Germline met mutations in mice reveal mutation- and background-associated differences in tumor profiles

p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs

Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

Critical analysis of the potential for microRNA biomarkers in breast cancer management

UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Expression profiling and identification of novel genes in hepatocellular carcinomas

A Mouse Model of Activating Met Mutations

MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance

NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer

Suchergebnisse filtern